The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2009, 182, 6071 -6078
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0804064

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ghoreishi, M.
Right arrow Articles by Dutz, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ghoreishi, M.
Right arrow Articles by Dutz, J. P.

Expansion of Antigen-Specific Regulatory T Cells with the Topical Vitamin D Analog Calcipotriol1

Mehran Ghoreishi*, Paxton Bach*, Jennifer Obst*, Mitsuhiro Komba*, James C. Fleet{dagger} and Jan P. Dutz2,*

* Department of Dermatology & Skin Science and Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada; and {dagger} Purdue University, West Lafayette, IN 47901

1,25-Dihydroxyvitamin D3 is immunosuppressive both in vivo and in vitro. Topical vitamin D analogs such as calcipotriol alter keratinocyte function, but their effects on cutaneous immune responses are less well understood. We demonstrate that exposure of the skin to calcipotriol before transcutaneous immunization with OVA protein and CpG adjuvant prevents Ag-specific CD8+ T cell priming coincident with Langerhans cell depletion in the skin. Immunization through calcipotriol-treated skin induces CD4+CD25+ regulatory T cells (Treg) that prevent subsequent Ag-specific CD8+ T cell proliferation and IFN-{gamma} production. Treg induced by calcipotriol are able to inhibit the induction and the elicitation of protein contact hypersensitivity. Topical calcipotriol treatment also induces RANKL (receptor activator of NF-{kappa}B ligand) expression by keratinocytes, a TNF family member involved in modulation of skin dendritic cells. UV light B induces Ag-specific tolerance when it is applied before transcutaneous immunization. We suggest that UV light B-induced tolerance is induced via a vitamin D receptor-dependent mechanism as vitamin D receptor (VDR) knockout mice fail to increase FoxP3+ Treg in their peripheral draining lymph node following irradiation. Additionally, keratinocytes of VDR–/– mice fail to induce RANKL upon UV irradiation or calcipotriol treatment. The in vivo expansion of Ag-specific Treg with the topical application of the vitamin D analog calcipotriol followed by transcutaneous immunization is a simple method to augment functional Ag-specific CD4+CD25+Foxp3+ Treg populations and mimics Ag-specific UV-induced tolerance.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by the Canadian Institutes of Health Research (MOP-81083), Juvenile Diabetes Research Foundation International (Award 4-2004-223), and the Canadian Dermatology Foundation. J.P.D. is a Senior Scholar of the Michael Smith Foundation for Health Research.

2 Address correspondence and reprint requests to Dr. Jan P. Dutz, Department of Dermatology & Skin Science, Child and Family Research Institute, University of British Columbia, 835 West Tenth Avenue, Vancouver, British Columbia V5Z 4E8, Canada. E-mail address: dutz{at}interchange.ubc.ca

3 Abbreviations used in this paper: Treg, regulatory T cell; CHS, contact hypersensitivity; DC, dendritic cell; KO, knockout; LC, Langerhans cell; LN, lymph node; VD3, 1,25-dihydroxyvitamin D3; RANKL, receptor activator of NF-{kappa}B ligand; TCI, transcutaneous immunization; VDR, vitamin D receptor.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.